-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhongke Biotech (01237) Fa Yingxi expects net profit attributable to shareholders to increase year-on-year to about 16 million yuan in the medium term

Zhitongcaijing·08/26/2026 14:17:03
Listen to the news

According to the Zhitong Finance App, Zhongke Biotech (01237) announced that for the six months ending June 30, 2026, the Group expects to obtain net profit attributable to shareholders of approximately RMB 16 million (six months ending June 30, 2025: net profit of RMB 8.8 million), mainly due to improvements in the gross profit margin of products sold by the Group for the six months ended June 30, 2026.